• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 021368 Product 004 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N021368 004 5859006 Nov 21, 2017 Y Y
N021368 004 6140329 Jul 11, 2016 Y U - 155
N021368 004 6821975 Nov 19, 2020 Y Y U - 533
N021368 004 6821975 Nov 19, 2020 Y Y U - 614
N021368 004 6943166 Apr 26, 2020 U - 155
N021368 004 7182958 Apr 26, 2020 Y U - 155

Exclusivity Data

Appl No Prod No Exclusivity Code Exclusivity Expiration
N021368 004 I - 641 Oct 6, 2014
N021368 004 I - 642 Oct 6, 2014


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through August 2014
Patent and Generic Drug Product Data Last Updated September 29, 2014

-
-